Interferon-beta: treatment option against COVID-19

  • Faiz Ul Haq | faizulhaq553@gmail.com Department of Microbiology University of Health Sciences Lahore; Center for Biotechnology and Microbiology University of Swat, Pakistan. http://orcid.org/0000-0002-9391-0032
  • Muhammad Usman Khan Department of Pharmacology University of Health Sciences Lahore, Pakistan.
  • Ayesha Muazzam Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Hajrah Farooq Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Javeria Iqbal Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Muhammad Imran Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Rabia Bashir Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Sania Ahmad Department of Microbiology University of Health Sciences Lahore, Pakistan.
  • Sara Arif Department of Microbiology University of Health Sciences Lahore, Pakistan.

Abstract

In December 2019, an increasing number of cases of novel coronavirus (2019-nCoV) that were linked to seafood wholesale market have identified in Wuhan, China. Taxonomist declared 2019-nCoV as severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) and the disease termed as COVID-19. Importantly, there is no approved drugs or vaccine against SARS-CoV-2. Current review is related to address treatment option for COVID-19. Interferon-β have shown significant activity against previous outbreak of SARS-CoV and MERS-CoV. Faced with an ongoing pandemic of SARS-CoV-2 and lack of effective treatment options, identifying compounds with antiviral activity has become a high priority. Efficacy of these treatments is still unclear. Therefore, final analysis is important to develop better treatment strategies for ongoing pandemic.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-07-06
Info
Issue
Section
Perspective Articles
Keywords:
Coronavirus, antiviral agents, Interferon-β, SARS-CoV-2, COVID-19.
Statistics
  • Abstract views: 384

  • PDF: 75
How to Cite
Ul Haq, F., Khan, M., Muazzam, A., Farooq, H., Iqbal, J., Imran, M., Bashir, R., Ahmad, S., & Arif, S. (2020). Interferon-beta: treatment option against COVID-19. Geriatric Care, 6(3). https://doi.org/10.4081/gc.2020.9093